Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Assertio Holdings, Inc. (ASRT : NSDQ)

• Company Description    Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill. Number of Employees: 53

• Price / Volume Information    Yesterday's Closing Price: $23.44 Daily Weekly Monthly 20 Day Moving Average: 485,978 shares Shares Outstanding: 6.46 (millions) Market Capitalization: $151.47 (millions) Beta: 0.44 52 Week High: $23.46 52 Week Low: $8.61 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 30.08% 23.72% 12 Week 95.82% 81.03% Year To Date 158.43% 136.89%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 100 S. Saunders Road Suite 300 - Lake Forest,IL 60045 USA ph: 224-419-7106 fax: 510-744-8001 investor@assertiotx.com http://www.assertiotx.com

• General Corporate Information    Officers Mark L. Reisenauer - Chief Executive Officer and Director Heather L. Mason - Chairman Ajay Patel - Executive Vice President and Chief Financial Offic Sravan K. Emany - Director Sigurd C. Kirk - Director Peer Information Assertio Holdings, Inc. (GSAC) Assertio Holdings, Inc. (CASIF) Assertio Holdings, Inc. (ALCD.) Assertio Holdings, Inc. (OMNN) Assertio Holdings, Inc. (CGPI.) Assertio Holdings, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 04546C304 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/10/26 Share - Related Items Shares Outstanding: 6.46 Most Recent Split Date: 12.00 (0.07:1) Beta: 0.44 Market Capitalization: $151.47 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.07 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.03 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/26

• Fundamental Ratios P/E Current FY Estimate: 781.33 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.00 Price/Cash Flow: 1,433.64 Price / Sales: 1.48 EPS Growth vs. Year Ago Period: -39.59% vs. Previous Quarter: -57.53% Sales Growth vs. Year Ago Period: -62.50% vs. Previous Quarter: -26.65% ROE 03/31/26 - -38.72 12/31/25 - -30.26 09/30/25 - -26.99 ROA 03/31/26 - -13.32 12/31/25 - -10.59 09/30/25 - -9.93 Current Ratio 03/31/26 - 1.82 12/31/25 - 1.70 09/30/25 - 1.58 Quick Ratio 03/31/26 - 1.57 12/31/25 - 1.51 09/30/25 - 1.43 Operating Margin 03/31/26 - -34.94 12/31/25 - -25.59 09/30/25 - -21.06 Net Margin 03/31/26 - -34.94 12/31/25 - -25.59 09/30/25 - -21.06 Pre-Tax Margin 03/31/26 - -34.71 12/31/25 - -25.22 09/30/25 - -21.07 Book Value 03/31/26 - 11.70 12/31/25 - 14.63 09/30/25 - 16.48 Inventory Turnover 03/31/26 - 1.16 12/31/25 - 1.17 09/30/25 - 1.29 Debt-to-Equity 03/31/26 - 0.52 12/31/25 - 0.42 09/30/25 - 0.37 Debt-to-Capital 03/31/26 - 34.17 12/31/25 - 29.40 09/30/25 - 27.02

Powered by Zacks Investment Research ©